A 4-year-old boy with a 2-year history of multiple seizure types presents with recurrent episodes of sudden falls causing head injuries, incomplete loss of awareness lasting 10–20 seconds, and nocturnal stiffening of the trunk and extremities lasting 5–10 seconds. His parents report progressive cognitive decline. EEG shows the pattern marked **A** in the diagram. Which of the following is the MOST appropriate first-line antiepileptic drug combination for this patient, given the specific EEG finding?

Explanation

## Why Valproate combined with lamotrigine or rufinamide is right The EEG pattern marked **A** — generalized slow spike-and-wave at 1.5–2.5 Hz with frontal predominance — is pathognomonic for Lennox-Gastaut syndrome (LGS), a severe childhood epileptic encephalopathy. The clinical triad of tonic seizures (nocturnal stiffening), atypical absences (gradual onset/offset, incomplete awareness), and drop attacks (causing falls and head injury) confirms LGS. Valproate (15–60 mg/kg/day) is the gold-standard first-line agent; it is combined with lamotrigine (titrated slowly to avoid Stevens-Johnson syndrome) or rufinamide (FDA-approved specifically for LGS, especially effective for drop attacks). This combination addresses the multiple seizure types characteristic of LGS. [Adams and Victor's Principles of Neurology 12e Ch 16; Nelson Pediatrics 21e Ch 611] ## Why each distractor is wrong - **Carbamazepine combined with oxcarbazepine**: Both are sodium channel blockers that are CONTRAINDICATED in LGS because they worsen absence and myoclonic seizures, potentially exacerbating atypical absences and drop attacks. - **Phenytoin monotherapy with vigabatrin**: Phenytoin is a sodium channel blocker (contraindicated in LGS) and vigabatrin is known to worsen myoclonic and absence seizures; neither is appropriate for this syndrome. - **Levetiracetam combined with gabapentin**: While levetiracetam may be used as an adjunct, gabapentin is contraindicated in LGS as it can worsen absence seizures; this combination lacks valproate, the essential first-line anchor. **High-Yield:** Slow spike-wave (1.5–2.5 Hz) = LGS; avoid sodium channel blockers; valproate + lamotrigine/rufinamide is the gold standard. [Adams and Victor's Principles of Neurology 12e Ch 16; Nelson Pediatrics 21e Ch 611]